Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • ClinOne Names Clinical Research Technology Leader Andrea Valente Chief Executive Officer

    Mar 11, 2022, 14:08 PM by
    Valente brings strategic leadership, industry, product and operational experience needed at a pivotal moment in the company’s exponential growth
    Full story
  • CD Formulation Offers Customized Synthesis to Meet the Demand for Lipid Excipients

    Mar 11, 2022, 14:08 PM by
    As a New York-based CRO company, CD Formulation has keenly observed that the demand for tailored pharmaceutical excipients is on the rise, especially over the past decade, as each formulation project may need unique excipients. In response to such a market trend, the management of CD Formulation earlier this month announces to offer customized synthesis for lipid excipients, which are used in lipid-based dosage forms for the enhancement of drug absorption or delivery.
    Full story
  • Nanomaterial News Update: Alfa Chemistry Upgrades Its Nanoprism Product Line

    Mar 11, 2022, 14:08 PM by
    Full story
  • Optibrium Adds Augmented Intelligence for Compound Design to its StarDrop Small Molecule Drug Discovery Software

    Mar 11, 2022, 14:08 PM by
    Optibrium Ltd, a leading developer of software for drug discovery, today announced the release of the latest version of StarDrop™, its comprehensive software platform for small molecule design, optimisation and data analysis. More than 160 organisations currently use StarDrop, including many of the world’s leading pharmaceutical companies. The new release introduces Inspyra™, a module that dynamically learns from chemists’ expert knowledge and feedback to guide automated compound design methods, creating a powerful ‘augmented intelligence’ to accelerate the discovery of high-quality drug candidates.
    Full story
  • Digital Health Companies Orbita and OnCall Health Choose Lyniate for Reliable Interoperability

    Mar 11, 2022, 14:08 PM by
    Full story
  • Domainex expands analytical chemistry capabilities with over £1M worth of new Waters equipment

    Mar 11, 2022, 14:08 PM by
    Cambridge, United Kingdom, 3rd March 2022 / Sciad Newswire / Domainex Ltd., a leading integrated medicines research services partner, announces that it has purchased over £1M worth of new Waters equipment to enhance its capabilities in analytical chemistry, bioanalytical sciences and in vitro absorbance, distribution, metabolism and excretion (ADME) assays. The new equipment will allow Domainex to increase its capacity and throughput, supporting its ongoing growth.
    Full story
  • WuXi STA Passes the First EMA Drug Product Pre-Approval Inspection at its Wuxi City Site

    Mar 11, 2022, 14:08 PM by
    Full story
  • Qlucore receives second commercial order for new solution

    Mar 11, 2022, 14:08 PM by
    The Swedish Nasdaq First North listed software company Qlucore, focused on cancer diagnostics, has signed an agreement with the Molecular Oncohematology Research Group at the Department of Pathology and Experimental Cancer Research at Semmelweis University. The group will use Qlucore’s software to improve diagnostics of acute lymphoblastic leukemia (ALL) and collaborate on a new classification model using the Trusight Pan-Cancer panel.
    Full story
  • SGD Pharma launches industry first Ready-to-Use sterile 100 ml molded glass vials in SG® EZ-fill® packaging technology

    Mar 11, 2022, 14:08 PM by
    Puteaux Cedex, FRANCE – 1st March: Worldwide glass primary packaging supplier SGD Pharma has announced the introduction of its 100H* ml Ready-to-Use (RTU) Type I molded glass vials for aseptic fill/finish of parenteral drug products.
    Full story
  • Male fertility diagnostics leaders, Examen, now offer semen analysis testing for men in Belfast

    Mar 11, 2022, 14:08 PM by
    Examen, leaders in male fertility research and diagnostics, is delighted to announce that semen analysis is now available at its Belfast facility. This comes in response to unprecedented demand for fertility services as couples continue to face delays in accessing appointments owing to the backlog caused by the pandemic.
    Full story
  • Cotiviti to Present on Strategies to Align Payer and Provider Risk Adjustment Programs within Value-Based Care at 2022 RISE National Summit

    Mar 11, 2022, 14:08 PM by
    Summit to be co-chaired by Cotiviti Executive Vice President RaeAnn Grossman
    Full story
  • UK Regulator Cites CluePoints’ Solutions in Updated Guidance

    Mar 11, 2022, 14:08 PM by
    UK Regulator Cites CluePoints’ Solutions in Updated Guidance MHRA shares CluePoints case study to demonstrate the value of statistical monitoring in clinical trial oversight and monitoring King of Prussia, PA – 7th March 2022: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, has been cited in the updated Good Clinical Practice (GCP) guidance from the UK’s MHRA, putting the agency´s considerable weight behind CluePoints’ industry-leading statistical monitoring solutions.
    Full story
  • Alfa Chemistry Announces Completion of Building a Sub-website for Polymer Stabilizers

    Mar 11, 2022, 14:08 PM by
    Full story
  • CD Formulation Announces Ability to Achieve Solubility Improvement and Bioavailability Enhancement for Drug Formulation Projects

    Mar 11, 2022, 14:08 PM by
    Full story
  • Oxford Medical Products raises £2.5 million for its hydrogel weight-loss platform technology

    Mar 11, 2022, 14:08 PM by
    Oxford Medical Products has raised £2.5M in equity investment to conduct first human trials of Sirona, its innovative non-surgical weight-loss solution. Sirona is a hydrogel-based technology in a tablet format that, once swallowed, expands in the stomach, stops feelings of hunger and suppresses appetite.
    Full story
  • Aragen acquires Intox Pvt. Ltd

    Mar 11, 2022, 14:08 PM by
    Full story
  • Watson-Marlow Fluid Technology Group drives growth with new Operations and Supply Director

    Mar 11, 2022, 14:08 PM by
    Abdul Butt joins Watson-Marlow Fluid Technology Group as Operations and Supply Director to drive the company’s supply excellence and enable continued growth. Abdul joins the company with extensive experience in Manufacturing and Operational Excellence, including 20 years at GKN PLC and then Melrose Industries as CEO of one of their divisions, followed by MPP where he was Chief Operating Officer in his most recent role.
    Full story
  • NanoSyrinx appoints R&D industry leader Dr Marie McAvoy as Chief Scientific Officer

    Mar 11, 2022, 14:08 PM by
    NanoSyrinx has strengthened its management team with the appointment of Dr Marie McAvoy as its Chief Scientific Officer.
    Full story
  • Senior Biopharma Executive Joins MMS Holdings as Principal Medical Director

    Mar 11, 2022, 14:08 PM by
    MMS Holdings, a data-focused contract research organization (CRO), announced the addition of Robert Allen, MD, to its team as Principal Medical Director of Global Drug Safety and Pharmacovigilance.
    Full story
  • Vyasa Introduces Cortex: Intuitive, Visual Data Fabric Creation & Management

    Mar 11, 2022, 14:08 PM by
    Vyasa, an innovative provider of highly scalable deep learning A.I. analytics software for healthcare, life sciences and business applications, today debuts its latest application, Cortex. An intuitive data management tool, Cortex acts as the “blueprint” of the data fabric by allowing users to build, manage and provision access to data sources connected to Vyasa Layar data fabrics.
    Full story
  • «
  • 151
  • 152 (current)
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy